The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood

Journal of Neuro-Oncology

Volumn 95, Issue 2, 2009, Pages 239-245

  Kruer, Michael C ^a,b   Kaplan, Allen M ^a   Etzl Jr , Michael M ^a   Carpentieri, David F ^a   Dickman, Paul S ^a   Chen, Kewei ^c   Mathieson, Kathleen ^d   Irving, Alison ^c  

^a PHOENIX CHILDREN'S HOSPITAL   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Banner Samaritan Regional Medical Center   (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Low grade astrocytoma; Positron emission tomography; Progressive disease; Proliferation index

Indexed keywords

FLUORODEOXYGLUCOSE F 18; KI 67 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PROGNOSIS; PROGRESSION FREE SURVIVAL; SCHOOL CHILD; TUMOR CLASSIFICATION; TUMOR GROWTH;

ADOLESCENT; ASTROCYTOMA; BRAIN NEOPLASMS; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DISTRIBUTION;

EID: 70350022427     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9922-4     Document Type: Article

References (24)

1. Dirks PB, Jay V, Becker LE (1994) Development of anaplastic changes in low-grade astrocytomas of childhood. Neurosurgery 34:68-78. doi: 10.1097/ 00006123-199401000-00010
2. Mason WP (2005) Progress in clinical neurosciences: Advances in the management of low-grade gliomas. Can J Neurol Sci 32:18-26
3. Stupp R, Janzer RC, Hegi ME et al (2003) Prognostic factors for low-grade gliomas. Semin Oncol 30(suppl):23-28. doi: 10.1053/ j.seminoncol.2003.11.029
4. Utriainen M, Metsahonkala L, Salmi TT et al (2002) Metabolic characterization of childhood brain tumors: Comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography. Cancer 95:1376-1386. doi: 10.1002/cncr.10798
5. Giammarile F, Cinotti LE, Jouvet A et al (2004) High and low grade oligodendrogliomas (ODG): Correlation of amino-acid and glucose uptakes using PET and histological classifications. J Neurooncol 68:263-274. doi: 10.1023/B:NEON.0000033384.43417.82
6. Torii K, Tsuyuguchi N, Kawabe J et al (2005) Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas. Ann Nucl Med 19:677-683. doi: 10.1007/BF02985116
7. Kwon JW, Kim IO, Cheon JE et al (2006) Paediatric brain-stem gliomas: MRI, FDG-PET and histological grading correlation. Pediatr Radiol 36:959-964. doi: 10.1007/s00247-006-0256-5
8. Kaplan AM, Bandy DJ, Manwaring KH et al (1999) Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors. J Neurosurg 91:797-803
9. Reinges MH, Krings T, Meyer PT et al (2004) Preoperative mapping of cortical motor function: Prospective comparison of functional magnetic resonance imaging and [15O]-H2O-positron emission tomography in the same co-ordinate system. Nucl Med Commun 25:987-997. doi: 10.1097/ 00006231-200410000-00002
10. Ribom D, Eriksson A, Hartman M et al (2001) Positron emission tomography (11) C-methionine and survival in patients with low-grade gliomas. Cancer 92:1541-1549. doi: 10.1002/ 1097-0142(20010915)92:6<1541::AID-CNCR1480>3.0.CO;2-D
11. De Witte O, Oulad-Ben-Taib N, Branle F et al (2004) Contribution of PET to the management of patients with low-grade glioma. Neurochirurgie 50:468-473. doi: 10.1016/S0028-3770(04)98327-0
12. Nariai T, Tanaka Y, Wakimoto H et al (2005) Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 103:498-507
13. McKeever PE, Strawderman MS, Yamini B et al (1998) MIB-1 proliferation index predicts survival among patients with grade II astrocytoma. J Neuropathol Exp Neurol 57:931-936. doi: 10.1097/00005072-199810000-00005
14. Giannini C, Scheithauer BW, Burger PC et al (1999) Cellular proliferation in pilocytic and diffuse astrocytomas. J Neuropathol Exp Neurol 58:46-53. doi: 10.1097/00005072-199901000-00006
15. Bowers DC, Gargan L, Kapur P et al (2003) Study or the MIB-1 labeling indexing as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. J Clin Oncol 21:2968-2973. doi: 10.1200/ JCO.2003.01.017
16. Prayson RA (2005) The utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms. Adv Anat Pathol 12:144-148. doi: 10.1097/01.pap.0000163957.21409.52
17. Johannessen AL, Torp SH (2006) The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas. Pathol Oncol Res 12:143-147. doi: 10.1007/BF02893360
18. Woods RP, Mazziotti JC, Cherry SR (1993) MRI PET Registration with automation algorithm. J Comput Assist Tomogr 17:536-546. doi: 10.1097/ 00004728-199307000-00004
19. Wisoff JH, Sanford A, Holmes E et al (2003) Impact of surgical resection on low grade gliomas of childhood: A report from the CCG9891/POG9130 low grade astrocytoma study. [Abstract] ASCO. Annual meeting
20. Shaw EG, Wisoff JH (2003) Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro Oncol 5:153-160. doi: 10.1215/S1152851702000601
21. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50:1316-1322
22. 11C] L-methionine to metabolically characterize dysembryoplastic neuroepithelial tumors. J Child Neurol 4:673-677. doi: 10.1177/ 088307389901401009
23. 18F-FDG PET. Eur J Nucl Med Mol Imaging 29:176-182. doi: 10.1007/s00259-001-0690-4
24. 11C] methionine-positron emission tomographic and magnetic resonance imaging for image-guided surgical resection of infiltrative low-grade brain tumors in children. Neurosurgery 57:128-139. doi: 10.1227/01.NEU.0000163598.59870.6D